These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2399187)

  • 1. [Monotherapy with acebutolol in hypertensive diabetic patients].
    Leowski J; Czech A; Lastowiecki P; Jaskóła K; Tatoń J
    Pol Tyg Lek; 1990 Jan 1-15; 45(1-3):30-5. PubMed ID: 2399187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Microalbuminuria in diabetics with moderate hypertension].
    Valensi P; Ferrière F; Attali JR; Erault C; Modigliani E; Delrieux C; Sebaoun J
    Arch Mal Coeur Vaiss; 1986 Jun; 79(6):785-9. PubMed ID: 3099693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid identification of diabetic patients with essential hypertension sensitive to acebutolol.
    Passa P; Tugaye A; Gauville C; Canivet J
    Diabete Metab; 1981 Sep; 7(3):155-9. PubMed ID: 7033007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of nifedipine in the treatment of arterial hypertension in various types of diabetes mellitus].
    Leowski J; Czech A; Gadomska M; Lastowiecki P; Laz R; Tatoń L
    Pol Tyg Lek; 1990 Feb 5-12; 45(6-7):117-22. PubMed ID: 2216950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal function, glycemic control and perindopril in diabetic patients.
    Brichard S; Ketelslegers JM; Lambert AE
    Clin Exp Hypertens A; 1989; 11 Suppl 2():545-54. PubMed ID: 2691128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative effect of lisinopril and lacidipine on urinary albumin excretion in patients with type 11 diabetic nephropathy.
    Salako BL; Finomo FO; Kadiri S; Arije A; Olatosin AO
    Afr J Med Med Sci; 2002 Mar; 31(1):53-7. PubMed ID: 12518931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Spirapril - a new long-acting ACE inhibitor: efficacy and safety in patients with arterial hypertension in combination with diabetes mellitus and impaired kidney function].
    Iakusevich VV; Mozheĭko ME; Paliutin ShKh; Berezina MIu; Martsevich SIu; Shal'nova SA; Deev AD; Kutishenko NP; Alimova EV; Koniakhina IP; Semenova IuE
    Ter Arkh; 2000; 72(10):82-6. PubMed ID: 11220887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes.
    Estacio RO; Jeffers BW; Gifford N; Schrier RW
    Diabetes Care; 2000 Apr; 23 Suppl 2():B54-64. PubMed ID: 10860192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study.
    Roglic G; Colhoun HM; Stevens LK; Lemkes HH; Manes C; Fuller JH
    Diabet Med; 1998 May; 15(5):418-26. PubMed ID: 9609365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril and microalbuminuria in diabetic and non-diabetic hypertension.
    Kelleher CC; Ferriss JB; Cole M; O'Sullivan DJ
    J Hum Hypertens; 1987 Dec; 1(3):181-3. PubMed ID: 2852253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased blood pressure in diabetes: essential hypertension or diabetic nephropathy?
    Christensen CK; Krusell LR; Mogensen CE
    Scand J Clin Lab Invest; 1987 Jun; 47(4):363-70. PubMed ID: 3602914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group.
    Schmidt S; Giessel R; Bergis KH; Strojek K; Grzeszczak W; Ganten D; Ritz E
    Nephrol Dial Transplant; 1996 Sep; 11(9):1755-61. PubMed ID: 8918618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.
    Agardh CD; Garcia-Puig J; Charbonnel B; Angelkort B; Barnett AH
    J Hum Hypertens; 1996 Mar; 10(3):185-92. PubMed ID: 8733038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH; Kim KB; Kim DL; Kim SG; Choi KM; Baik SH; Choi DS; Kang YS; Han SY; Han KH; Ji YH; Cha DR
    Diabet Med; 2004 Jun; 21(6):545-51. PubMed ID: 15154937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albuminuria and the renin-angiotensin system gene polymorphisms in type-2-diabetic and in normoglycemic hypertensive Chinese.
    Thomas GN; Critchley JA; Tomlinson B; Lee ZS; Young RP; Cockran CS; Chan JC
    Clin Nephrol; 2001 Jan; 55(1):7-15. PubMed ID: 11200871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
    Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
    J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of ACE inhibitors on renal function in incipient and overt diabetic nephropathy.
    Parving HH
    J Diabetes Complications; 1996; 10(3):133-5. PubMed ID: 8807457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index in type 2 diabetes mellitus complications: hypertensive diabetics and diabetic nephropathy.
    Idogun ES; Unuigbe EI; Famodu AA; Akinola OT
    Niger Postgrad Med J; 2006 Mar; 13(1):17-20. PubMed ID: 16633373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
    Eijkelkamp WB; Zhang Z; Remuzzi G; Parving HH; Cooper ME; Keane WF; Shahinfar S; Gleim GW; Weir MR; Brenner BM; de Zeeuw D
    J Am Soc Nephrol; 2007 May; 18(5):1540-6. PubMed ID: 17409317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.